A doctor holds the Pfizer BioNTech vaccine and syringe to protect against the coronavirus disease. (Photo: lakshmiprasada S/Shutterstock)
For millions of Americans, the emergency authorization of two COVID-19 vaccines by the federal government was a bright spark of hope in what has been an otherwise bleak pandemic winter. Indeed, according to preliminary modeling from Verisk's Life Risk Navigator platform, the United States could potentially achieve the long-sought herd immunity by the fall of 2021 thanks, in part, to these very vaccines.
Want to continue reading?
Become a Free PropertyCasualty360 Digital Reader
Your access to unlimited PropertyCasualty360 content isn’t changing.
Once you are an ALM digital member, you’ll receive:
- All PropertyCasualty360.com news coverage, best practices, and in-depth analysis.
- Educational webcasts, resources from industry leaders, and informative newsletters.
- Other award-winning websites including BenefitsPRO.com and ThinkAdvisor.com.
Already have an account? Sign In
© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
